Raising the Bar for Survival in High-Risk HR+, HER2- EBC: Real-World Strategies to Improve Risk Assessment, Candidate Identification, and Treatment Selection and Delivery in the Adjuvant Setting
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
IPCE CreditsUp to 0.75 creditsAAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits
MOC types
ABIM — Medical KnowledgeUp to 0.75 pointsABIM — Patient SafetyUp to 0.75 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 174 W 4th Street
Pricing
100% of listed courses are free
300 of a sample of 300 are free · 321 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Communication & Shared Decision-Making
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Internal Medicine
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Infectious Disease
- Maternal-Fetal Medicine
- Medical Genetics & Genomics
- Medical Oncology
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Rhinology
- Surgical Oncology
- Thoracic Surgery
- Urological Oncology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
- Commercial Support
-
ReleasedMar 27, 2026
-
Last day to claim creditMar 27, 2027 6 months left
-
PVI, PeerView Institute for Medical Education Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC
-
PVI, PeerView Institute for Medical Education Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence
-
Living Beyond Breast Cancer +1 PeerView Live, Mapping the Complex Testing and Treatment Terrain in HR+, HER2- MBC and EBC: Evidence-Based and Algorithm-Guided Solutions to Real-World Clinical Challenges
-
Q Synthesis +2 Mitigating Recurrence Risk: A Multisite QI Initiative to Improve Clinical Outcomes and Management in Patients With High-Risk HR+/HER2- EBC
-
Efficient CME, CME Outfitters, LLC Reshaping the Paradigm in Hormone Receptor Positive, HER2-negative Early Breast Cancer: How Next Generation SERDs May Challenge the Adjuvant Treatment Landscape
-
Medical Learning Institute, Inc. Nursing Voices from the Frontline: Adjuvant CDK4/6 Therapy in HR+ HER2- Breast Cancer
